StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
0201.KL$0.34+1.52%
Fair $0.34+0.0%

0201.KL

Nova Wellness Group Berhad

Consumer Defensive / Packaged FoodsKuala Lumpur

$0.34

+0.00 (+1.52%)

Fairly Valued+0.0%Fair Value $0.34Fund rank 23/100 · Data gapFallback financials|
SA 31/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $1.5M · quality 30.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

31/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 0201.KLLocal privado en este navegador · Nova Wellness Group Berhad
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$107M

P/E

11.2x

↓

EV/EBITDA

8.5x

↓

ROE

7.0%

↑

Gross Margin

55.2%

↑

Debt/Equity

N/A

•
52-Week Range$0
$0$0

TradingView lightweight chart

0201.KL price, volumen y niveles de valoración

Último $0.335Periodo -55.9%
Fair value: $0.335

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-3.5%

FCF CAGR

-15.5%

FCF margin

3.4%

FCF / Net income

0.19x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $44.1M · net income $7.7M · FCF $1.5M

2022-FY → 2025-FY

Gross margin

55.2%-13.9% pts

Operating margin

21.5%-16.4% pts

Net margin

17.5%-15.3% pts

FCF margin

3.4%-1.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$44.1M$44.1M$40.8M$45.5M$49.1M
Net Income$7.7M$7.7M$7.9M$15.0M$16.1M
EBITDA$12.4M$12.4M$12.5M$20.3M$21.2M
EPS0.020.020.020.050.05
Gross Margin55.2%55.2%57.4%70.4%69.1%
Operating Margin21.5%21.5%23.6%39.4%37.9%
Net Margin17.5%17.5%19.3%32.9%32.8%
Balance Sheet
Current Ratio13.7813.78———
Cash Flow
Free Cash Flow$1.5M$1.5M$3.9M$-2.5M$2.5M
Returns
ROE7.0%7.0%7.2%14.1%16.0%
Valuation
P/E11.1711.1721.4614.6816.77
EV/EBITDA8.488.4813.3310.8112.69
P/B0.970.971.542.082.69
Growth & Yield
Revenue Growth8.1%8.1%-10.3%-7.3%—
EPS Growth-1.6%-1.6%-47.4%-7.3%—
Dividend Yield9.6%9.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

6.9%

razonable

EPS terminal req.

$0.03

Spread vs growth

-8.6%

5Y implied EPS CAGR

8.2%

razonable

EPS terminal req.

$0.04

Spread vs growth

-9.8%

10Y implied EPS CAGR

9.1%

razonable

EPS terminal req.

$0.06

Spread vs growth

-10.7%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +21.2%

Total return

+21.2%

Start / end P/E

12.1x → 13.8x

EPS bridge

0.02 → 0.02

Residual

-0.2%

EPS growth-1.6%
Multiple rerating+13.5%
Dividend+9.6%
Residual / FX / buybacks / cross-term-0.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.